BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 35301483)

  • 1. Immunological barriers to haematopoietic stem cell gene therapy.
    Charlesworth CT; Hsu I; Wilkinson AC; Nakauchi H
    Nat Rev Immunol; 2022 Dec; 22(12):719-733. PubMed ID: 35301483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation.
    Canarutto D; Omer Javed A; Pedrazzani G; Ferrari S; Naldini L
    Br Med Bull; 2023 Sep; 147(1):108-120. PubMed ID: 37460391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of gene-modified haematopoietic stem cells: Application and clinical considerations.
    Alessandrini M; Krause KH; Speck RF; Pepper MS
    S Afr Med J; 2019 Sep; 109(8b):64-69. PubMed ID: 31662152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of hematopoietic stem cells: mission accomplished?
    Takizawa H; Schanz U; Manz MG
    Swiss Med Wkly; 2011; 141():w13316. PubMed ID: 22252776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease.
    Germino-Watnick P; Hinds M; Le A; Chu R; Liu X; Uchida N
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameters affecting successful stem cell collections for genetic therapies in sickle cell disease.
    Justus DG; Manis JP
    Transfus Apher Sci; 2021 Feb; 60(1):103059. PubMed ID: 33541761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.
    Heinz N; Ehrnström B; Schambach A; Schwarzer A; Modlich U; Schiedlmeier B
    Stem Cells Transl Med; 2015 Sep; 4(9):1064-72. PubMed ID: 26160960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.
    Lee BC; Lozano RJ; Dunbar CE
    Mol Ther; 2021 Nov; 29(11):3205-3218. PubMed ID: 34509667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-like protein 3 promotes preservation of stemness during ex vivo expansion of murine hematopoietic stem cells.
    Farahbakhshian E; Verstegen MM; Visser TP; Kheradmandkia S; Geerts D; Arshad S; Riaz N; Grosveld F; van Til NP; Meijerink JP
    PLoS One; 2014; 9(8):e105642. PubMed ID: 25170927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding hematopoietic stem cell ex vivo: recent advances and technical considerations.
    Rubio-Lara JA; Igarashi KJ; Sood S; Johansson A; Sommerkamp P; Yamashita M; Lin DS
    Exp Hematol; 2023; 125-126():6-15. PubMed ID: 37543237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell gene editing and expansion: State-of-the-art technologies and recent applications.
    Haltalli MLR; Wilkinson AC; Rodriguez-Fraticelli A; Porteus M
    Exp Hematol; 2022 Mar; 107():9-13. PubMed ID: 34973360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo hematopoietic stem cell expansion technologies: recent progress, applications, and open questions.
    Meaker GA; Wilkinson AC
    Exp Hematol; 2024 Feb; 130():104136. PubMed ID: 38072133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation.
    Wilkinson AC; Ishida R; Kikuchi M; Sudo K; Morita M; Crisostomo RV; Yamamoto R; Loh KM; Nakamura Y; Watanabe M; Nakauchi H; Yamazaki S
    Nature; 2019 Jul; 571(7763):117-121. PubMed ID: 31142833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 genome editing in human hematopoietic stem cells.
    Bak RO; Dever DP; Porteus MH
    Nat Protoc; 2018 Feb; 13(2):358-376. PubMed ID: 29370156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LNK (SH2B3) inhibition expands healthy and Fanconi anemia human hematopoietic stem and progenitor cells.
    Holdreith N; Lee G; Chandra V; Salinas CS; Nicholas P; Olson TS; Tong W
    Blood Adv; 2022 Feb; 6(3):731-745. PubMed ID: 34844262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial.
    Brendel C; Rio P; Verhoeyen E
    Biochem Pharmacol; 2020 Apr; 174():113711. PubMed ID: 31726047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo expansion of hematopoietic stem cells and gene therapy development.
    Zubler RH
    Swiss Med Wkly; 2006 Dec; 136(49-50):795-9. PubMed ID: 17299657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physioxia improves the selectivity of hematopoietic stem cell expansion cultures.
    Igarashi KJ; Kucinski I; Chan YY; Tan TK; Khoo HM; Kealy D; Bhadury J; Hsu I; Ho PY; Niizuma K; Hickey JW; Nolan GP; Bridge KS; Czechowicz A; Gottgens B; Nakauchi H; Wilkinson AC
    Blood Adv; 2023 Jul; 7(14):3366-3377. PubMed ID: 36809781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional aspects of factor VIII expression after transplantation of genetically-modified hematopoietic stem cells for hemophilia A.
    Ide LM; Iwakoshi NN; Gangadharan B; Jobe S; Moot R; McCarty D; Doering CB; Spencer HT
    J Gene Med; 2010 Apr; 12(4):333-44. PubMed ID: 20209485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.